The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, randomized phase 2 study evaluating the efficacy and safety of HLX43 (an anti-PD-L1 ADC) in recurrent/metastatic esophageal squamous cell carcinoma.
 
Linlin Wang
No Relationships to Disclose
 
Qi Dang
No Relationships to Disclose
 
Yuan Yuan
No Relationships to Disclose
 
Huang Yunjian
No Relationships to Disclose
 
Jin Zhou
No Relationships to Disclose
 
Shoumei Yang
No Relationships to Disclose
 
Meili Sun
No Relationships to Disclose
 
Shegan Gao
No Relationships to Disclose
 
Ruinuo Jia
No Relationships to Disclose
 
Leilei Yuan
No Relationships to Disclose
 
Lin Zhao
No Relationships to Disclose
 
Mudan Yang
No Relationships to Disclose
 
Yanqiao Zhang
No Relationships to Disclose
 
Jiang Zhao
Employment - Shanghai Henlius Biotech
 
Xiaoli Hou
Employment - Shanghai Henlius Biotech
 
Haoyu Yu
Employment - Shanghai Henlius Biotech
 
Jing Li
Employment - Shanghai Henlius Biotech
 
Qingyu Wang
Employment - Shanghai Henlius Biotech
 
Jun Zhu
Employment - Shanghai Henlius Biotech
 
Jinming Yu
No Relationships to Disclose